Borghi C - Search Results

1

Pharmacokinetics, pharmacodynamics and clinical efficacy of non-statin treatments for hypercholesterolemia.

Cicero AFG, Bove M, Borghi C. Cicero AFG, et al. Among authors: borghi c. Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):9-15. doi: 10.1080/17425255.2018.1416094. Epub 2017 Dec 13. Expert Opin Drug Metab Toxicol. 2018. PMID: 29231064 Review.

2

Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia.

Borghi C, Prandin MG, Costa FV, Bacchelli S, Degli Esposti D, Ambrosioni E. Borghi C, et al. J Cardiovasc Pharmacol. 2000 Apr;35(4):549-55. doi: 10.1097/00005344-200004000-00006. J Cardiovasc Pharmacol. 2000. PMID: 10774784 Clinical Trial.

3

Interactions between hypercholesterolemia and hypertension: implications for therapy.

Borghi C. Borghi C. Curr Opin Nephrol Hypertens. 2002 Sep;11(5):489-96. doi: 10.1097/00041552-200209000-00003. Curr Opin Nephrol Hypertens. 2002. PMID: 12187312 Review.

4

[Hypercholesterolemia as cardiovascular risk in hypertensive patients. Therapeutic implications: efficiency of statins].

Borghi C, Veronesi M. Borghi C, et al. Recenti Prog Med. 2003 Oct;94(10):421-6. Recenti Prog Med. 2003. PMID: 14619187 Review. Italian.

5

A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.

Borghi C, Bacchelli S, Degli Esposti D, Ambrosioni E. Borghi C, et al. Expert Opin Pharmacother. 2004 Sep;5(9):1965-77. doi: 10.1517/14656566.5.9.1965. Expert Opin Pharmacother. 2004. PMID: 15330734 Review.

6

Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.

Borghi C, Cicero AF. Borghi C, et al. Vasc Health Risk Manag. 2006;2(4):341-9. doi: 10.2147/vhrm.2006.2.4.341. Vasc Health Risk Manag. 2006. PMID: 17323587 Free PMC article. Review.

7

Detection of familial combined hyperlipoproteinaemia patients in the Brisighella Heart Study historical cohort: an epidemiological approach.

Cicero AF, Manca M, Bove M, Dormi A, Borghi C, Gaddi AV; Brisighella Heart Study group. Cicero AF, et al. Among authors: borghi c. J Inherit Metab Dis. 2007 Apr;30(2):268. doi: 10.1007/s10545-007-0372-x. Epub 2007 Mar 8. J Inherit Metab Dis. 2007. PMID: 17347918 No abstract available.

8

Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial.

Cicero AF, Derosa G, Manca M, Bove M, Borghi C, Gaddi AV. Cicero AF, et al. Among authors: borghi c. Clin Exp Hypertens. 2007 Aug;29(6):383-94. doi: 10.1080/10641960701578378. Clin Exp Hypertens. 2007. PMID: 17729055 Free article. Clinical Trial.

9

Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure.

Borghi C, Veronesi M, Cosentino E, Cicero AF, Kuria F, Dormi A, Ambrosioni E. Borghi C, et al. J Hypertens. 2007 Oct;25(10):2051-7. doi: 10.1097/HJH.0b013e32827759a6. J Hypertens. 2007. PMID: 17885547

10

Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease.

Cicero AF, Derosa G, Manca M, Bove M, Borghi C, Gaddi AV. Cicero AF, et al. Among authors: borghi c. Endothelium. 2007 Jul-Oct;14(4-5):193-8. doi: 10.1080/10623320701606731. Endothelium. 2007. PMID: 17922335

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

895 results

Search Page

Filters